Detection of cell surface GLUT4 by immunofl uorescence
Immunofl uorescence was used to detect GLUT4 on the cell surface using a previously published method with slight modifi cations ( 17 ) . L6-GLUT4 myc cells were seeded on a glass-bottomed plate overnight. After treatment with PA or insulin, cells were immediately placed on ice and washed three times with ice-cold KrebsRinger HEPES buffer (KRBH) (120 mM NaCl, 25 mM HEPES, 4.6 mM KCl, 1 mM MgSO 4 , 1.2 mM KH 2 PO 4 , and 1.9 mM CaCl 2 , pH 7.4). After blocking with 5% goat serum in KRBH at 4°C for 10 min, cells were incubated with 2.5 mg/ml anti-myc polyclonal antibody at 4°C for 1 h, washed with ice-cold KRBH, fi xed in 3% formaldehyde (PFA) at 4°C for 20 min, and then incubated with 50 mM NH 4 Cl for another 10 min. After washing with KRBH, cells were incubated with fl uorescein isothiocyanat (FITC)-conjugated goat anti-rabbit IgG (1:500 dilution) for 45 min at 4°C, washed with ice-cold KRBH, and then examined immediately in KRBH with an Olympus FV500 confocal fl uorescence microscope.
Measurement of 2-deoxy-D-[

H]glucose uptake
L6-GLUT4 myc cells were treated with PA, washed three times with prewarmed KRBH, and incubated in KRBH containing 0.5 Ci/ml 2-deoxy-D-[ 3 H]glucose and 50 M 2-deoxy-glucose at 37°C for 5 min. Cells were then washed three times with ice-cold KRBH and then lysed with 1% SDS. Radioactivity was measured using a Perkin-Elmer scintillation counter. Each experiment was performed three times at least with triplicate independently.
Protein preparation and Western blotting
After the treatments indicated, cells were lysed directly with 2×SDS sample buffer and sonicated twice (7 s each time) at 200 W. Rat tissue samples were prepared according to a previously published method ( 18 ) . Briefl y, 50-70 mg wet tissues were sonicated in 2×SDS sample buffer to dissolve cellular protein, and total protein was precipitated using 7.2% TCA. Protein pellets were washed with acetone and dissolved in 2×SDS sample buffer by sonication. Total proteins were resolved by 10% SDS-PAGE, transferred to a polyvinylidene fl uoride membrane, blotted using the antibodies indicated, and detected using ECL.
Palmitate treatment of rat skeletal muscle
Male Sprague-Dawley rats (200-250 g) were anesthetized intraperitoneally with chloral hydrate (10%, 1 ml/200 g body weight) and subjected to transcardiac perfusion with 20 ml 2 mM PA in saline containing 10% FBS. The success of perfusion was confi rmed by loss of color in the liver. After perfusion, the soleus muscle strips were isolated, incubated in 2 mM PA in saline containing 10% FBS at 37°C for the times indicated, immediately frozen in liquid nitrogen, and stored at Ϫ 80°C until required. All animal experiments were approved by the Institutional Animal Care and Use Committee and followed the Animal Use Guidelines of the Institute of Biophysics, Chinese Academy of Sciences.
Lipid extraction and TLC
The cells were lysed with 1% triton X-100 after treatment with 3 H-labled PA and total lipids were extracted with lipid extract reagent (chloroform-methanol-acetic acid = 50:50:1, by vol) for TLC. Chromatograms were developed with the developing solvent of whereas palmitic acid (PA) treatment was reported to inhibit insulin-stimulated but not basal glucose uptake ( 13 ) .
To elucidate the mechanism underlying the response of skeletal muscle to acute increases in fatty acids, we examined the acute effects of PA on glucose uptake and on phosphorylation of AMP-activated protein kinase (AMPK), Akt, and extracellular signal-related kinase (ERK) 1/2 in skeletal cell lines. We found that PA stimulated GLUT4 translocation to the plasma membrane and glucose uptake enhancement. Our data also suggest that PI3 kinase (PI3K), AMPK, Akt, and ERK1/2 play critical roles in PAinduced glucose uptake and that cell surface-bound PA is suffi cient to trigger the signal transduction.
MATERIALS AND METHODS
Materials
Sodium PA, insulin, myc polyclonal antibody, fatty acid-free BSA, 5-aminoimidazole-4 carboxamide 1-␤-D-ribofuranoside (AICAR), Compound C, API-2, Lipid Standard, and 2-deoxy-Dglucose were purchased from Sigma-Aldrich (St. Louis, MO).
2-Deoxy-D-[
3 H]glucose and TLC plates were obtained from GE Healthcare (UK). Antibodies against phosphorylated Akt (Ser 473), total Akt, phosphorylated AMPK (Thr172), phosphorylated ERK1/2 (p44/42 MAPK) (Thr202/Tyr204), and GAPDH were from Cell Signaling Technology (Beverly, MA). Myc monoclonal antibody was purchased from Upstate (Billerica, MA). 3 H-PA was from PerkinElmer Life Sciences (Waltham, MA). LY294002 and API-2 were from Biomol (Plymouth Meeting, PA). PD98058 and U0126 were from Beyotime Institute of Biotechnology (Haimen, China). Short interference RNA (siRNA) duplex targeting Akt (siAkt) and AMPK and negative control siRNA were from GenePharma (Shanghai, China). The L6-GLUT4 myc (L6) cell line, a rat skeletal muscle cell line which stably over-expresses GLUT4, was obtained from Dr. Amira Klip, Division of Cell Biology, Hospital for Sick Children, Toronto, Canada. The myc-tagged AMPK dominant negative mutant constructed into pcDNA3.1 was a kind gift from Dr. David Carling, Cellular Stress Group, MRC Clinical Sciences Centre, London, UK.
Cell culture
L6-GLUT4 myc cells were maintained in ␣ -minimal essential medium ( ␣ -MEM) supplemented with 10% (v/v) FBS, 2 µg/ml blasticidin S, 100 units/ml penicillin, and 100 units/ml streptomycin at 37°C with 5% CO 2 . L6 cells were differentiated into myotubes within 7 days in medium supplemented with 2% FBS. Mouse C2C12 myoblasts (American Type Culture Collection) were maintained in DMEM supplemented with 10% (v/v) FBS, 100 units/ml penicillin, and 100 units/ml streptomycin at 37°C with 5% CO 2 .
Palmitate preparation and treatment
Sodium palmitate was prepared according to our previously published method ( 14 ) . Briefl y, sodium palmitate was added to ethanol to a fi nal concentration of 100 mM and sonicated on ice at 200 W using 10 s on, 3 s off pulses until the mixture became a milky homogenous solution. The PA stock solution was added to growth medium containing 10% FBS at 60°C and the medium was cooled to 37°C for cell treatment unless otherwise stated. For the control, the same amount of ethanol was added to the growth medium containing 10% FBS as a vehicle. expresses GLUT4 with a myc tag located in its fi rst exofacial loop, L6-GLUT4 myc (L6), was treated with 300 M PA or 100 nM insulin. As shown in Fig. 1A , insulin increased plasma membrane-localized GLUT4 as expected. Surprisingly, PA treatment also stimulated GLUT4 translocation to the plasma membrane. We then measured glucose uptake in L6 cells treated with PA. Uptake of 3 H-labeled 2-deoxy-glucose in L6 cells was increased by 28% ( P < 0.05), 69% ( P < 0.001), 76% ( P < 0.001), 93% ( P < 0.001), 86% ( P < 0.001), and 85% ( P < 0.001) after 5, 10, 15, 20, 30 , and 60 min of treatment with 300 M PA, respectively ( Fig. 1B ) . The increased glucose uptake in skeletal muscle cells acutely exposed to PA correlated with the localization of GLUT4 on the plasma membrane.
Palmitate stimulates phosphorylation of Akt, AMPK, and ERK1/2
Because the stimulatory effect of PA on GLUT4 translocation and glucose uptake was similar to that of insulin, we N-hexane-diethyl ether-acetic acid (80:20:1, by vol), and then the TLC plates were stained in iodine vapor after being air-dried at room temperature for 20 min. The silica gel of the plates was scraped following the separated lipid bands from Lipid Standard and subjected to scintillation counting using a Perkin-Elmer scintillation counter.
Statistical analyses
Statistical analyses were performed using Microsoft Offi ce Excel 2007 and OriginPro 7.5. Differences among relevant groups were assessed using unpaired Student's t -tests. P < 0.05 was considered signifi cant. Values presented are means ± SD.
RESULTS
Palmitate stimulates GLUT4 translocation and basal glucose uptake
To determine the acute effect of PA on glucose uptake in skeletal muscle, a rat skeletal muscle cell line that stably . Cells were lysed in 2× SDS sample buffer and total protein was subjected to Western blotting using the antibodies indicated. GAPDH was included as an internal control. E: A total of 2 mM palmitate in saline containing 10% FBS was used to perfuse male Sprague-Dawley rats. After perfusion, isolated soleus muscle strips were incubated in 2 mM palmitate at 37°C for the times indicated. Control rats were treated with 10% FBS-containing saline. The cost times for each step are indicated in supplementary examined the activation of Akt, a key protein involved in insulin-stimulated GLUT4 translocation. Akt phosphorylation (Ser 473) was stimulated by PA in a time-and dosedependent manner ( Fig. 1C-E and supplementary Fig.  IA) . Interestingly, activation of Akt in L6 myoblasts was observed after 10 min and peaked at 45 min, then decreased dramatically after 1 h, and became nondetectable after 3 h ( Fig. 1C ), suggesting that a signal transduction cascade initiated by PA leads to the activation of Akt. In addition, PA also could stimulate Akt activation in differentiated L6 myotubes but made a shorter duration of Akt activation compared with L6 myoblasts (supplementary Fig. IA) . To verify the stimulatory effect of PA on Akt activation, we carried out similar experiments using mouse skeletal muscle cell line C2C12, and, as a result, PA also activated Akt rapidly ( Fig. 2A , lanes 1 to 5). Further verifi cation was carried out using rat skeletal muscle. After anesthetization, rats were perfused with 2 mM PA. Skeletal muscle strips were collected and then incubated in vitro with 2 mM PA ( Fig.  1E and supplementary Fig. IF) . Similar to the results obtained from experiments using cell lines, PA stimulated Akt phosphorylation in rat skeletal muscle tissue ( Fig. 1E ,  lane 8) . Together, these data suggest that this acute response of PA may be physiologically relevant because results were similar for mouse and rat skeletal muscle cell lines as well as rat skeletal muscle tissue. We then investigated this putative PA-mediated signaling pathway in more detail. Previous studies have shown that chronic treatment with PA can induce AMPK phosphorylation ( 19, 20 ) and that AMPK is able to induce Akt activation ( 21 ) . Therefore, we tested whether AMPK can also be activated by PA treatment. Our data show that short-term treatment with PA is also able to stimulate AMPK phosphorylation (Thr172) starting as early as 5 min and reaching a peak at 20 min. After 1 h, the signal could not be detected ( Fig. 1C ) . As AMPK activation takes place more rapidly than Akt activation, it is possible that AMPK may mediate PA-induced Akt activation. In addition, phosphorylation of AMPK and Akt was stimulated by PA in a dose-dependent manner ( Fig.  1D ). Besides PA, we also examined the acute effects of other plasma-abundant fatty acids on skeletal muscle cells. Interestingly, linoleic acid, oleic acid, and stearic acid all could acutely stimulate Akt and AMPK phosphorylation in a dose-dependent manner in L6 cells (supplementary Fig.  IB, C, and D) . Furthermore, the combination of PA, linoleic acid, oleic acid, and stearic acid had similar effects (supplementary Fig. IE) , of which ratio mimicked the fatty acid concentration ratio in rat plasma ( 22 ) .
During PA short-term treatment, besides AMPK and Akt, ERK1/2 was also stimulated. The Western blot results showed that phosphorylation of both p44 (Thr202) and p42 (Tyr204) was increased after 5 min and returned to basal level after 15 min ( Fig. 1F ). ERK1/2 stimulation implied that it might participate PA-induced glucose uptake.
Cell surface-bound palmitate stimulates Akt phosphorylation
Acute responses of rat skeletal muscle cells to PA (activation of AMPK, Akt, ERK1/2, and stimulation of glucose 11, lane 14) . A total of 100 nM insulin in prewarmed KRBH buffer was used to treat cells at 37°C for 20 min (lane 12) as a positive control. After incubation, cells were lysed and total protein was subjected to Western blotting using the antibodies indicated. GAPDH was included as an internal control. K, KRBH; B, BSA; ins, insulin. B: Cells were treated with 300 M PA plus 0.2 Ci/ml 3 Hlabeled PA at 4°C for 1 h and washed three times with ice-cold KRBH buffer or 0.4% fatty acid-free BSA solution. Cells were then lysed and radio-labeled lipids were measured by scintillation counting. Data are presented as means ± SD (n = 3). Bar 1: total input. Bar 2: 
Activation of Akt is involved in palmitate-stimulated glucose uptake
The above experiments showed that PA could acutely stimulate glucose uptake and Akt activity, suggesting that Akt may be involved in PA-induced glucose uptake. We applied an Akt selective inhibitor API-2 ( 23 ) to block Akt activity. As a result, API-2 could abolish Akt phosphorylation ( Fig. 3A ) as well as decrease PA-induced glucose uptake signifi cantly ( Fig. 3B ) . In addition, Akt expression was reduced by RNA interference to verify the results from experiments using inhibitor. siRNA duplexes were nucleofected into L6 cells and total Akt expression levels were determined at 24, 48, and 72 h after nucleofection. Compared with negative control siRNA (N.C.), siAkt could effi ciently downregulate Akt expression ( Fig. 3C ) . As Fig.  3D shows, in further analyses performed at 48 h after nucleofection, siAkt transfection decreased PA-induced glucose uptake, whereas N.C. transfection did not. Together, these data suggest that PA-triggered signal transduction induces glucose uptake in skeletal muscle cells via Akt activation.
Activation of AMPK is involved in palmitate-stimulated Akt phosphorylation and glucose uptake
Because AMPK and Akt activation was observed sequentially in PA-treated cells ( Fig. 1C ) , we studied the relationship between AMPK and Akt and the role of AMPK in PA-induced glucose uptake. AMPK agonist AICAR was used to stimulate AMPK phosphorylation in L6 cells, and the Western blots showed that not only uptake) indicate that PA may function as a soluble factor that can stimulate skeletal muscle cells by binding to the surface membrane in order to transduce its signal. To test this hypothesis, PA binding to mouse skeletal muscle C2C12 cells was achieved by incubating cells with PA for 1 h at 4°C to avoid PA internalization. Cells were then washed with ice-cold KRBH to remove unbound PA and transferred to 37°C to activate signal transduction. Akt phosphorylation appeared after 5 min ( Fig. 2A , lane 8) , reached a maximum at 10 min (lane 9), and declined thereafter, similar to the time-dependent manner of Akt activation at 37°C. However, when 0.4% fatty acid-free BSA-containing KRBH was used to wash the cells, Akt phosphorylation could not be detected (lane 14) , suggesting that binding of PA to the cell surface is necessary for acute Akt stimulation. We conducted the same experiment with trace amounts of 3 H-labeled PA and found that the effective amount of PA was as little as 0.43% of the original amount of PA applied ( Fig. 2B ) . To investigate the metabolism of PA during the PA treatment, the total lipids were extracted and separated by TLC. The data showed that fatty acid is the majority (79.8% ± 1.1%) of the total lipids from the cells after washing by KRBH buffer at 4°C ( Fig. 2C , group 1) and still the main composition (62.4% ± 4.6%) after 10 min incubation at 37°C ( Fig. 2C , group 3) . The content of PA was signifi cant different between KRBH washing and BSA washing, whereas phospholipids, monoacylglycerol, diacylglycerol, and triglyceride did not change significantly ( Fig. 2C , group 1 vs. group 2) . These data indicate that PA is the factor to induce Akt activation. Fig. 3 . Akt is involved in palmitate-stimulated glucose uptake. A: L6 cells were pretreated with or without API-2 at indicated concentrations for 30 min and then with or without 300 M PA alone or with inhibitor for 30 min, and total cell lysates were subjected to Western blotting. B: L6 cells were treated with 2 M API-2 and 300 M PA as in A and then 3 H-labeled 2-deoxy-D-glucose uptake assays were performed. Data are presented as means ± SD (n = 3) from one of three time-independent experiments with triplicate. Differences between PA alone and PA with API-2 were determined using the Student's t -test. * P < 0.05. C: L6 cells were nucleofected with siRNA targeting Akt (siAkt) or negative control siRNA (N.C.). The cells were harvested after the indicated transfection times, and the total cell lysates obtained were subjected to Western blotting. D: L6 cells were nucleofected as in C and treated with 300 M PA for 30 min after 48 h of transfection.
3 H-labeled 2-deoxy-D-glucose uptake assays were performed. Data are presented as means ± SD (n = 3) from one of three time-independent experiments with triplicate. Differences in PA effects between N.C.-transfected cells and siAkt-transfected cells were determined using the Student's t -test. * P < 0.05. and AMPK-DN was expressed ( Fig. 4D ) , PA-induced Akt phosphorylation ( Fig. 4E ) and glucose uptake ( Fig. 4F ) were also decreased. Furthermore, in the L6 cells transfected siRNA duplex mixture targeting AMPK catalytic subunits ␣ 1 and ␣ 2, AMPK ␣ expression level was dramatically decreased as expected ( Fig. 4G ) , and PA-stimulated Akt phosphorylation was also decreased ( Fig. 4H ) , consistent with the inhibitor and AMPK-DN experiments. These data showed that PA-stimulated AMPK phosphorylation AMPK but also Akt was stimulated rapidly by AICAR treatment in a time-dependent manner ( Fig. 4A ) , which suggests that it is possible to stimulate Akt via AMPK activation in L6 cells. On the contrary, when we used AMPK inhibitor Compound C to suppress AMPK activity, we found Compound C could decrease PA-induced Akt phosphorylation ( Fig. 4B ) and glucose uptake ( Fig. 4C ) . Moreover, when the myc-tagged AMPK dominant negative (AMPK-DN) plasmid was nucleofected into L6 cells 3 H-labeled 2-deoxy-D-glucose uptake assays were performed. Data are presented as means ± SD (n = 3) from one of four time-independent experiments with triplicate. Differences between PA alone and PA with Compound C were determined using the Student's t -test. * P < 0.05. D: L6 cells were nucleofected with pcDNA3.1 or AMPK-DN plasmids. After 48 h of transfection, cells were lysed and total proteins were obtained to analyze with anti-myc monoclonal antibody. E: L6 cells were transfected as in D and treated with or without 300 M PA for 30 min. Cells were lysed in 2× SDS sample buffer, and total protein was subjected to Western blotting using the antibodies indicated. F: L6 cells were transfected and treated as in E and then subjected to 3 H-labeled 2-deoxy-D-glucose uptake assays. Data are presented as means ± SD (n = 3) from one of three time-independent experiments with triplicate. Differences in PA effects between mock and AMPK-DN-transfected cells were determined using the Student's t -test. * P < 0.05. G: L6 cells were nucleofected with siRNA duplex mixture targeting AMPK ␣ 1 and ␣ 2 or negative control siRNA (N.C.). The cells were harvested after the indicated transfection times and the total cell lysates obtained were subjected to Western blotting. H: L6 cells were nucleofected as in G and treated with or without 300 M PA for 30 min after 48 h of transfection. The cells were lysed, and the total proteins obtained were subjected to Western blotting. The images are from different lanes of the same gel. ( Fig. 5A ), suggesting that PI3K played an essential role in the cell response to PA. The Western blot results showed that PI3K inhibitor could reduce PA-induced AMPK activation ( Fig. 5B ) and block Akt phosphorylation ( Fig. 5C ). All the above data indicated that PA could rapidly trigger signal transduction by binding might contribute to regulate Akt activity and was involved in PA-induced glucose uptake.
PI3K mediates palmitate-stimulated glucose uptake by regulating AMPK and Akt activation
Because PI3K is upstream of Akt in the insulin signal pathway, we applied LY294002, a specifi c PI3K inhibitor, to the cells to determine whether PI3K functions in PA- Results from previous studies on adipocytes indicate that short-term treatment with fatty acids increases basal glucose uptake ( 13, 28, 29 ) . Some reports provide evidence that fatty acids share at least part of a common pathway with insulin ( 13 ) , whereas other reports indicate the involvement of GLUT1 but not GLUT4 ( 30 ); a consistent picture of the mechanisms involved has not yet emerged. More importantly, less is known about the situation in skeletal muscle cells. Here, we studied the short-term effects of PA in skeletal muscle cell lines and tissues, and results indicate that PA-stimulated glucose uptake occurs via activation of the PI3K/AMPK/Akt and PI3K/ERK1/2 pathways to lead GLUT4 translocation ( Fig. 6 ) .
Insulin receptor autophosphorylation has been observed after acute PA treatment in isolated adipocytes ( 13 ) , and in our work, we found that plasma membranebound PA was suffi cient to induce Akt phosphorylation, indicating that PA might interact with some protein(s) on the plasma membrane to trigger the signal. However, the identity of this protein(s) still needs to be determined.
Phosphorylation of Akt was stimulated only when the concentrations of PA reached a certain level (at or above 200 M in C2C12 cells). Thus, we concluded that phosphorylation of Akt may require high concentrations of fatty acids under physiological situations. According to our results, Akt phosphorylation was detectable after fatty acid treatments of up to 3 h ( Fig. 2A ) , and when fatty acids were withdrawn, the Akt phosphorylation signal disappeared after 3 h in C2C12 cells (data not shown), suggesting that fatty acid-induced phosphorylation and dephosphorylation of Akt can be completed within one fatty acid cycle. Many abnormal fatty acid cycles might contribute to the development of insulin resistance via the desensitization of Akt.
The most signifi cant implication of the above results is that PA can play two opposing roles in skeletal muscle. On one hand, under chronic treatment, it can inhibit insulininduced glucose uptake by blocking Akt phosphorylation, and on the other hand, when cells are exposed to PA for a short time, it can enhance glucose uptake by activating Akt. This Yin-Yang balance of PA in skeletal muscle must be physiologically signifi cant and needs to be investigated further.
to cell plasma membrane and stimulate glucose uptake via activation of PI3K/AMPK/Akt cascade in skeletal muscle cells. The fi nding of the PI3K/AMPK/Akt pathway is consistent with recently published work by Youn et al ( 24 ) .
Activation of ERK1/2 is involved in palmitate-stimulated glucose uptake in an AMPK and Akt-independent manner
Because blocking AMPK or Akt activity only partially decreased PA-induced glucose uptake, we investigated other possible pathways. The role of ERK1/2 in PA-stimulated signal transduction was examined by the MAPK/ERK kinase (MEK) 1/2 inhibitors PD98056 and U0126. Both inhibitors could decrease basal and PA-induced ERK1/2 phosphorylation, whereas U0126 worked more effi ciently ( Fig. 5D ) . When ERK1/2 activity was inhibited by U0126, PA-induced glucose uptake was reduced signifi cantly ( Fig.  5E ). These data showed that PA-stimulated ERK1/2 phosphorylation may contribute to PA-induced glucose uptake. To determine the relationship between ERK1/2 and PI3K/AMPK/Akt pathways, fi rst, PI3K inhibitor LY294002 was used. The results showed that PA-stimulated ERK1/2 phosphorylation was dramatically decreased ( Fig. 5F , lane 6 vs. lane 2), suggesting PI3K was the upstream of ERK1/2 in PA-induced signal transduction. Second, in AMPK ␣ 1/ ␣ 2 siRNA transfected cells, ERK1/2 phosphorylation was still increased normally as N.C. cells after PA treatment ( Fig. 5G ) . Third, Akt inhibitor API-2 was used but did not affect PA-induced ERK1/2 phosphorylation ( Fig.  5F lane 4 vs. lane 2) , and fi nally, MEK1/2 inhibitors PD98056 and U0126 did not affect PA-induced Akt phosphorylation, either ( Fig. 5D ) . These results suggest that in PA acute effects ERK1/2 was involved in PA-induced glucose uptake and regulated by PI3K but independent of AMPK and Akt.
DISCUSSION
After meals, plasma free fatty acids respond to insulin ( 25 ) , acylation stimulating protein ( 26 ) , and other factors, decreasing rapidly to basal levels within 2 h. Thereafter, free fatty acids are released from adipocytes into the blood as an energy source. The plasma fatty acid concentration increases quickly and may reach about 400 M within several hours ( 10 ) . Therefore, the free fatty acid concentration in blood varies considerably from hour to hour and forms a wave in every postprandial period. Under pathological conditions, plasma fatty acids also vary constantly but display different patterns; for example, obese nondiabetic humans have higher plasma fatty acid concentrations of 600-800 M compared with healthy subjects ( 27 ) . However, how body tissues respond to the rapidly changing fatty acid levels remains unclear. Many studies have revealed that chronically elevated plasma free fatty acids play a critical role in the development of insulin resistance. Chronic fatty acid elevation may consist of many abnormal fatty acid cycles. Thus, studies on acute fatty acid effects and the cumulative effects of many acute fatty acid elevations may offer a different view for understanding the pathology of type 2 diabetes. Supplemental Material can be found at:
